Latest Rheumatology Stories
DANVERS, Mass., Aug. 19, 2014 /PRNewswire-USNewswire/ -- The Scleroderma Foundation presented a Lifetime Achievement Award to Virginia D.
Nearly 80 Percent of Surveyed Physicians Believe Xeljanz is Superior to Methotrexate in Inhibiting Structural Progression in RA, According to Findings from Decision Resources Group BURLINGTON,
Expert from the Largest Scleroderma Specialty Center in the U.S. at Johns Hopkins will Provide Insight to Help Patients, Physicians and Caregivers. SAN FRANCISCO, Aug.
A new mechanism of joint destruction caused by a natural material that grinds away healthy cartilage and worsens osteoarthritis has been identified in human hip joints for the first time by University of Liverpool scientists.
PITTSBURGH, Aug. 13, 2014 /PRNewswire/ -- As the most common form of inflammatory arthritis today, gout is growing in epidemic proportions in the United States.
Curriculum Developed by The Arthritis Society Toronto, ON (PRWEB) August 12, 2014 Pharmacists across the country will soon receive specialized training
A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged.
On September 17, $10 From Every Massage or Facial Benefits the Arthritis Foundation SCOTTSDALE, Ariz., Aug.
Arthritis is a very painful inflammation of one or more of a person’s joints. To better understand the condition, it is important to understand the common types that are regularly diagnosed.
With a new therapeutic product, researchers have managed to cure arthritis in mice for the first time.
- Emitting flashes of light; glittering.